![Elyse G. Seltzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elyse G. Seltzer
Corporate Officer/Principal chez
Yale University
Profil
Elyse G.
Seltzer is currently a Member at Yale University.
Previously, she held positions as a Principal at Centocor, Inc., Johnson & Johnson, and Vicuron Pharmaceuticals LLC.
From 2006 to 2009, she served as the Chief Medical Officer at Tengion, Inc. From 2009 to 2015, she was the Vice President-Global Clinical Sciences at GSK Plc.
In 2015 to 2017, she held the position of Chief Medical Officer at Nabriva Therapeutics GmbH.
In 2017, she briefly served as the Chief Medical Officer at Nabriva Therapeutics Plc.
Currently, she is the Chief Development Officer at UroGen Pharma Ltd. Dr. Seltzer completed her undergraduate degree at the University of Pennsylvania and obtained her doctorate from New York University School of Medicine.
Postes actifs de Elyse G. Seltzer
| Sociétés | Poste | Début |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Elyse G. Seltzer
| Sociétés | Poste | Fin |
|---|---|---|
| UROGEN PHARMA LTD. | Directeur Technique/Scientifique/R&D | 01/04/2020 |
| NABRIVA THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 30/09/2017 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Directeur Technique/Scientifique/R&D | 01/09/2017 |
| GSK PLC | Corporate Officer/Principal | 01/04/2015 |
| TENGION, INC. | Directeur Technique/Scientifique/R&D | 01/08/2009 |
Formation de Elyse G. Seltzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
